Jefferies Group’s Array Biopharma Inc ARRY Stock Holding History

Jefferies Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-80,696	Closed	-$3.74M	–	3247
2019 Q2	$3.74M	Buy	+80,696	New	+$2.27M	0.03%	610
2018 Q1	–	Sell	-14,475	Closed	-$185K	–	2942
2017 Q4	$185K	Buy	+14,475	New	+$165K	﹤0.01%	2243
2017 Q3	–	Sell	-143,349	Closed	-$1.2M	–	2737
2017 Q2	$1.2M	Buy	143,349 +37,737	+36%	+$309K	0.01%	1203
2017 Q1	$944K	Buy	+105,612	New	+$1.12M	0.01%	1305
2016 Q4	–	Sell	-51,220	Closed	-$346K	–	2621
2016 Q3	$346K	Buy	+51,220	New	+$198K	﹤0.01%	1757
2016 Q1	–	Sell	-5,675	Closed	-$24K	–	2728
2015 Q4	$24K	Buy	+5,675	New	+$25.9K	﹤0.01%	2175
2014 Q1	–	Sell	-50,000	Closed	-$251K	–	2507
2013 Q4	$251K	Buy	+50,000	New	+$272K	﹤0.01%	1475
2013 Q3	–	Sell	-100,387	Closed	-$456K	–	2309
2013 Q2	$456K	Buy	+100,387	New	+$540K	﹤0.01%	1107

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Jefferies Group's ARRY Position: Q3 2019 in Review

Jefferies Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 80,696 shares — an estimated $3.74M sold.

Jefferies Group first reported a position in ARRY in Q2 2013 and held it in 8 quarters. The position peaked at $3.74M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Jefferies Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Jefferies Group sold 80,696 Array Biopharma Inc shares in Q3 2019, an estimated $3.74M.
Jefferies Group first reported a position in Array Biopharma Inc in Q2 2013 and held it in 8 quarters.
Jefferies Group's Array Biopharma Inc position peaked at $3.74M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.